NCT05183100

Brief Summary

Post-stroke spasticity in the lower extremity affects balance and gait, leading to decreased mobility and functional independence. Therefore, effective intervention for reducing spasticity is crucial in stroke rehabilitation. Recently, neurodynamics, though originally designed for pain management in orthopedic patients, has also been applied for treating spasticity in patients with neurological disorders. However, previous studies focused mainly on treating the upper extremity spasticity, but not on lower extremity spasticity, and not on possible neurophysiological changes. The present study aims to investigate the immediate effects of neurodynamics in reducing lower limb spasticity and neurophysiological changes in people with chronic stroke.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 18, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 5, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 10, 2022

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 26, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 26, 2022

Completed
Last Updated

October 7, 2022

Status Verified

October 1, 2021

Enrollment Period

3 months

First QC Date

December 5, 2021

Last Update Submit

October 6, 2022

Conditions

Keywords

NeurodynamicsCalf muscle spasticityChronic stroke

Outcome Measures

Primary Outcomes (2)

  • Change in Spasticity: Clinical measurement

    The modified Ashworth scale (MAS) will be used, which is a 6-point scale commonly used to assess muscle spasticity in clinical settings.

    Before intervention and immediately after intervention

  • Change in Spasticity: Neurophysiological measurement

    The H-reflex will be recorded by placing a disposable surface electrode on the muscle belly of the gastrocnemius after a stimulation of the tibial nerve just proximal to the electrode.

    Before intervention and immediately after intervention

Secondary Outcomes (2)

  • Change in Gait Performance

    Before intervention and immediately after intervention

  • Change in Lower Extremity Motor Control

    Before intervention and immediately after intervention

Study Arms (2)

Experimental Condition (Neurodynamics Treatment)

EXPERIMENTAL

Neurodynamic treatment for about 13 minutes in supine position. It will be comprised of three stages, and the tensioner technique of the tibial nerve will be used.

Procedure: Tibial Nerve Neurodynamics

Control Condition

ACTIVE COMPARATOR

Lying in supine.

Procedure: Lying in supine

Interventions

The patient will lie supine with the trunk and neck in neutral position. During the first stage, participants will receive passive straight leg raise of the affected side held for 20 seconds for 3 repetitions. In the second stage, hip adduction and internal rotation, ankle dorsiflexion, and ankle eversion are added in the straight leg raise position. Slow oscillations of the ankle movement for 1 minute will be applied, followed by holding the position for 20 seconds, for 3 repetitions. In the third stage, the head of the patient will be held in flexion with pillows while the same oscillation procedure as the second stage is performed. There will be a 2-minute rest between the stages.

Also known as: Tibial Nerve Neural Mobilization
Experimental Condition (Neurodynamics Treatment)

Lying in supine position for about 13 minutes.

Control Condition

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosis of first-ever stroke with unilateral lesion for more than 6 months
  • demonstrating calf muscle spasticity as indicated by modified Ashworth scale equal to or greater than 1
  • with passive ROM of ankle dorsiflexion at least to neutral position (defined as 0°)
  • ability to walk at least 10m independently without a walking device or ankle-foot orthosis (AFO)
  • sufficient cognition (mini-mental state examination, MMSE score of 24 or higher)

You may not qualify if:

  • contraindications to nerve conduction tests
  • other orthopedic and neurological disorders interfering participating in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Yang Ming Chiao Tung University

Taipei, 112304, Taiwan

Location

Related Publications (3)

  • Lopez Lopez L, Torres JR, Rubio AO, Torres Sanchez I, Cabrera Martos I, Valenza MC. Effects of neurodynamic treatment on hamstrings flexibility: A systematic review and meta-analysis. Phys Ther Sport. 2019 Nov;40:244-250. doi: 10.1016/j.ptsp.2019.10.005. Epub 2019 Oct 15.

    PMID: 31655484BACKGROUND
  • Cha HK, Cho HS, Choi JD. Effects of the nerve mobilization technique on lower limb function in patients with poststroke hemiparesis. J Phys Ther Sci. 2014 Jul;26(7):981-3. doi: 10.1589/jpts.26.981. Epub 2014 Jul 30.

    PMID: 25140078BACKGROUND
  • Datta Gupta A, Visvanathan R, Cameron I, Koblar SA, Howell S, Wilson D. Efficacy of botulinum toxin in modifying spasticity to improve walking and quality of life in post-stroke lower limb spasticity - a randomized double-blind placebo controlled study. BMC Neurol. 2019 May 11;19(1):96. doi: 10.1186/s12883-019-1325-3.

    PMID: 31078139BACKGROUND

MeSH Terms

Conditions

Stroke

Interventions

Supine Position

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

PostureMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Ray-Yau Wang

    National Yang Ming Chiao Tung University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 5, 2021

First Posted

January 10, 2022

Study Start

October 18, 2021

Primary Completion

January 26, 2022

Study Completion

January 26, 2022

Last Updated

October 7, 2022

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

Locations